Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells

ConclusionsOur results highlight KRT17 as a possible biomarker in gastric cancer promoting tumor growth, motility, and invasion, and suggest that KRT17 can be a valuable molecular target for development of anti-gastric cancer-specific therapies.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research